Showing Results for
- Academic Journals (1,659)
Search Results
- 1,659
Academic Journals
- 1,659
-
From:Journal of Clinical Investigation (Vol. 131, Issue 19) Peer-ReviewedWe previously demonstrated that tumor-infiltrating lymphocytes (TIL) in human breast cancer sometimes form organized tertiary lymphoid structures (TLS) characterized by CXCL13-producing T follicular helper (Tfh) cells....
-
From:Annals of Indian Academy of Neurology (Vol. 14, Issue 3) Peer-ReviewedByline: Rakendra. Singh, Manjot. Kaur, Deepak. Arora Background and Objective: The nervous system is the most frequent and serious targets of human immunodeficiency virus (HIV) infection. In spite of a wide...
-
From:Indian Journal of Medical and Paediatric Oncology (Vol. 39, Issue 2) Peer-ReviewedByline: Mahtab. Rahbar, Mitra. Mehrazma, Mersedeh. Karimian Context: Neuroblastoma is often infiltrated by inflammatory cells, particularly macrophages and T lymphocytes, but the significance of these cells remains...
-
From:Nature (Vol. 591, Issue 7851) Peer-ReviewedRegulatory T (T.sub.reg) cells, although vital for immune homeostasis, also represent a major barrier to anti-cancer immunity, as the tumour microenvironment (TME) promotes the recruitment, differentiation and activity...
-
From:Ear, Nose and Throat Journal (Vol. 86, Issue 8) Peer-ReviewedAbstract The presence of tumor-infiltrating lymphocytes has been shown to significantly improve clinical outcomes in many types of cancer. However, their effects on outcomes in patients with oropharyngeal cancer...
-
From:Nature (Vol. 579, Issue 7798) Peer-ReviewedDespite the resounding clinical success in cancer treatment of antibodies that block the interaction of PD1 with its ligand PDL1.sup.1, the mechanisms involved remain unknown. A major limitation to understanding the...
-
From:PLoS ONE (Vol. 16, Issue 1) Peer-ReviewedAccumulating evidence has suggested a correlation of tumor infiltrating B cells (TiBcs) and a good prognosis of cancer diseases. In some cases, TiBcs appear to have experienced antigen stimulation since they have...
-
From:Science (Vol. 291, Issue 5510) Peer-ReviewedGADS is an adaptor protein implicated in CD3 signaling because of its ability to link SLP-76 to LAT. A GADS-deficient mouse was generated by gene targeting, and the function of GADS in T cell development and activation...
-
From:PLoS ONE (Vol. 13, Issue 10) Peer-ReviewedIn patients with triple-negative breast cancer (TNBC), tumor-infiltrating lymphocytes (TILs) are associated with improved survival. Lehmann et al. identified 4 molecular subtypes of TNBC [basal-like (BL) 1, BL2,...
-
From:PLoS ONE (Vol. 13, Issue 12) Peer-ReviewedTumor-infiltrating lymphocytes are related to positive clinical prognoses in numerous cancer types. Programmed death ligand 1 (PD-L1), a mediator of the PD-1 receptor, plays an inhibitory role in cancer immune...
-
From:Journal of Cancer Research and Therapeutics (Vol. 18, Issue 1) Peer-ReviewedByline: Senjuti. Dasgupta, Sudipta. Chakrabarti, Asit. Deb Background: Head-and-neck squamous cell carcinomas (HNSCCs) are one of the most common malignancies worldwide. Emerging evidence reveals that...
-
From:The Scientist (Vol. 17, Issue 17) Peer-ReviewedFor years, scientists largely ignored the lymphatic system, instead focusing on blood vessels and their growth process, called angiogenesis. Only since the mid-1990s has knowledge started to accumulate about the...
-
From:Diabetes (Vol. 61, Issue 11) Peer-ReviewedResidual [beta]-cells found at the time of clinical onset of type 1 diabetes are sufficient to control hyperglycemia if rescued from ongoing autoimmune destruction. The challenge, however, is to develop an immunotherapy...
-
From:Nature (Vol. 579, Issue 7797) Peer-ReviewedGroup 2 innate lymphoid cells (ILC2s) regulate inflammation and immunity in mammalian tissues.sup.1,2. Although ILC2s are found in cancers of these tissues.sup.3, their roles in cancer immunity and immunotherapy are...
-
From:Journal of Clinical Investigation (Vol. 132, Issue 9) Peer-ReviewedA combination of anti-CTLA-4 plus anti-PD-1/PD-L1 is the most effective cancer immunotherapy but causes high incidence of immune-related adverse events (irAEs). Here we report that targeting of HIF-1[alpha] suppressed...
-
From:BioMed Research International (Vol. 2020) Peer-ReviewedLung adenocarcinoma (LUAD) is a major pathological type of lung cancer. Understanding the mechanism of LUAD at the molecular level is important for a clinical decision. In this study, we use bioinformatic analysis to...
-
From:PLoS ONE (Vol. 8, Issue 4) Peer-ReviewedAuthor(s): Jessica Ann Chacon 1 , 2 , Richard C. Wu 1 , 2 , Pariya Sukhumalchandra 3 , Jeffrey J. Molldrem 2 , 3 , Amod Sarnaik 4 , Shari Pilon-Thomas 4 , Jeffrey Weber 4 , Patrick Hwu 1 , 2 , Laszlo Radvanyi 1 , 2 , *...
-
From:PLoS ONE (Vol. 13, Issue 4) Peer-ReviewedOne histopathological characteristic of intracranial germinoma is abundant tumor-infiltrating lymphocytes (TILs) showing a two-cell pattern with large undifferentiated tumor cells. The programmed cell death 1...
-
From:Nature (Vol. 565, Issue 7738) Peer-ReviewedPatients with glioblastoma currently do not sufficiently benefit from recent breakthroughs in cancer treatment that use checkpoint inhibitors.sup.1,2. For treatments using checkpoint inhibitors to be successful, a high...
-
From:PLoS ONE (Vol. 15, Issue 5) Peer-ReviewedAuthor(s): Dawit Wolday 1,*, Yazezew Kebede 1, Dorsisa Legesse 2, Dawd S. Siraj 3, Joseph A. McBride 3, Mitchell J. Kirsch 3, Robert Striker 3 Introduction Cumulative findings have demonstrated that antiretroviral...